Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Metagenomi (MGX) Consolidated Net Income (2023 - 2025)

Historic Consolidated Net Income for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to -$20.4 million.

  • Metagenomi's Consolidated Net Income fell 862.94% to -$20.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$88.7 million, marking a year-over-year decrease of 1999.08%. This contributed to the annual value of -$78.1 million for FY2024, which is 1436.23% down from last year.
  • Metagenomi's Consolidated Net Income amounted to -$20.4 million in Q3 2025, which was down 862.94% from -$19.9 million recorded in Q2 2025.
  • Metagenomi's Consolidated Net Income's 5-year high stood at -$10.7 million during Q2 2024, with a 5-year trough of -$25.1 million in Q1 2024.
  • Its 3-year average for Consolidated Net Income is -$18.8 million, with a median of -$19.8 million in 2023.
  • Examining YoY changes over the last 5 years, Metagenomi's Consolidated Net Income showed a top increase of 1744.31% in 2024 and a maximum decrease of 11422.61% in 2024.
  • Over the past 3 years, Metagenomi's Consolidated Net Income (Quarter) stood at -$19.3 million in 2023, then dropped by 21.27% to -$23.4 million in 2024, then grew by 12.84% to -$20.4 million in 2025.
  • Its Consolidated Net Income was -$20.4 million in Q3 2025, compared to -$19.9 million in Q2 2025 and -$25.0 million in Q1 2025.